About the company: ArborVita Associates (AVA) is a biotechnology company that has developed a simpler, faster, and cheaper way to modify DNA using a proprietary and patented enzyme called DRAP (Drosophila Recombination-Associated Protein).
ArborVita Associates is participating in the Edward L. Kaplan, ’71, New Venture Challenge, the University of Chicago’s premier start-up competition. The company is competing for the popular vote from the Built In Chicago community, and we encourage you to promote your favorite team by liking, tweeting, and spreading word about the company. The People’s Choice Award winner will be announced at the NVC finals on May 24 and will receive a cash prize. For more, see the original post.
